Molecular features of young cannabis smokers with advanced non-small cell lung cancer (aNSCLC)

被引：0
|
作者：
Aldea, M. [1 ]
Parisi, C. [1 ]
Mogenet, A. [1 ]
Cerbone, L. [2 ]
Vasseur, D. [3 ]
Lavaud, P. [1 ]
Naltet, C. [1 ]
Abdayem, P. [1 ]
Gazzah, A. [4 ]
Botticella, A. [5 ]
Levy, A. [5 ]
Le Pechoux, C. [5 ]
Le Pavec, J. [6 ]
Mercier, O. [6 ]
Rouleau, E. [3 ]
Besse, B. [1 ]
Soria, J-C. [4 ]
Barlesi, F. [1 ]
Pradere, P. [7 ]
Planchard, D. [1 ]
机构：
[1] Gustave Roussy, Med Oncol Dept, Villejuif, France
[2] Gustave Roussy, INSERM, U981, Villejuif, France
[3] Gustave Roussy, Dept Mol Biol, Villejuif, France
[4] Gustave Roussy, Drug Dev Dept DITEP, Villejuif, France
[5] Gustave Roussy, Radiotherapy Dept, Villejuif, France
[6] Marie Lannelongue Hosp, Thorac Surg Dept, Le Plessis Robinson, France
[7] Grp Hosp Paris St Joseph, Pneumonol, Le Plessis Robinson, France
来源：
ANNALS OF ONCOLOGY | 2021年 / 32卷
关键词：
D O I：
10.1016/j.annonc.2021.08.1945
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1344P
引用
收藏
页码：S1024 / S1025
页数：2
相关论文
共 50 条
  • [41] Treatment of advanced non-small cell lung cancer
    De Petris, L
    Crinò, L
    Scagliotti, GV
    Gridelli, C
    Galetta, D
    Metro, G
    Novello, S
    Maione, P
    Colucci, G
    de Marinis, F
    ANNALS OF ONCOLOGY, 2006, 17 : 36 - 41
  • [42] Chemotherapy for advanced non-small cell lung cancer
    Dubey, S
    Schiller, JH
    HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2004, 18 (01) : 101 - +
  • [43] Pemetrexed in advanced non-small cell lung cancer
    Gridelli, Cesare
    Maione, Paolo
    Rossi, Antonio
    Bareschino, Maria Anna
    Schettino, Clorinda
    Sacco, Paola Claudia
    Zeppa, Rosario
    EXPERT OPINION ON DRUG SAFETY, 2011, 10 (02) : 311 - 317
  • [44] Immunotherapy in Advanced Non-Small Cell Lung Cancer
    Huang, Joy
    Reckamp, Karen L.
    SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 41 (03) : 400 - 408
  • [45] Chemotherapy for advanced non-small cell lung cancer
    Thatcher, N
    LUNG CANCER, 2001, 34 : S171 - S175
  • [46] Pembrolizumab (Pem) for advanced non-small cell lung cancer (aNSCLC): Efficacy and safety in everyday clinical practice.
    Ksienski, Doran
    Wai, Elaine S.
    Croteau, Nicole
    Freeman, Ashley
    Fiorino, Leathia
    Chan, Angela
    Geller, Georgia Samantha
    Poonja, Zia
    Brooks, Edward Geoffrey
    Fenton, Dave
    Irons, Sarah
    Lesperance, Mary
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [47] Nivolumab treatment in advanced non-small cell lung cancer (aNSCLC): A French nationwide retrospective cohort (UNIVOC Study)
    Chouaid, C.
    Levra, M. Giaj
    Corre, R.
    Calvet, C.
    Gaudin, A-F.
    Grumberg, V.
    Jolivel, R.
    Jouaneton, B.
    Assie, J-B.
    Cotte, F-E.
    ANNALS OF ONCOLOGY, 2019, 30 : 521 - 521
  • [48] Temporal Trends in Treatment Patterns for Advanced/Metastatic Non-Small Cell Lung Cancer (aNSCLC) in Routine Clinical Practice
    Stefaniak, V.
    Winfree, K.
    Cui, Z.
    Molife, C.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S669 - S669
  • [49] Clinical impact of plasma next-generation sequencing (NGS) in advanced non-small cell lung cancer (aNSCLC)
    Bonanno, L.
    Pavan, A.
    Ferro, A.
    Calvetti, L.
    Frega, S.
    Pasello, G.
    Aprile, G.
    Guarneri, V.
    Conte, P. F.
    ANNALS OF ONCOLOGY, 2019, 30 : 577 - 577
  • [50] IMPLEMENTATION OF ADHERENCE TO ERLOTINIB (E) AS SECOND-LINE THERAPY FOR ADVANCED NON-SMALL CELL LUNG CANCER (ANSCLC)
    Gebbia, V.
    Bellavia, G.
    Russo, P.
    Banna, G. L.
    Ferrau, F.
    Tralongo, P.
    Borsellino, N.
    CANCER TREATMENT REVIEWS, 2010, 36 : S110 - S110
12345